Search Results 1-10 of 15465 for hla genotype

1. Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes - Mayo Clinic

   Clinical Trials · Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes · More about research at Mayo Clinic · Mayo Clinic Footer · Mayo ...

2. Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles - Mayo Clinic

   ... HLA-DQ genotype. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

3. A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers - Mayo Clinic

   Patient must have HLA-A*0201 genotype as determined by genomic testing. Patient must have histologically and/or cytologically proven tumor(s) that is WT1 ...

4. Identification of Non-gal, Non-HLA Antigens in Patients Implanted with Xenogenic Material - Mayo Clinic

   The purpose of this study is to identify non-HLA and non-gal protein antigens in transplanted xenogenic tissues (ie bovine or porcine pericardial heart valves) ...

5. Fractionated Anti HLA Antibodies Role in Prevention of Sold Organ Transplant Rejection - Mayo Clinic

   About this study. The purpose of this study is to develop single chain variable fragment antibodies against HLA A2 and test their efficacy in blocking the ...

6. HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide - Mayo Clinic

   The purpose of this study is to look at the effectiveness of using a study drug called cyclophosphamide (PTCy) to prevent graft versus host disease (GVHD) in ...

7. Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants - Mayo Clinic

   The primary objective of this study is to demonstrate the safety and efficacy of cellular immunotherapy with MDR-101 for induction of functional immune ...

8. HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis - Mayo Clinic

   The goal of this clinical trial is to determine the effectiveness of Reduced Dose Post-Transplant Cyclophosphamide (PTCy) in patients with hematologic ...

9. Daratumumab in Cardiac HLA Desensitization Prior to Transplantation - Mayo Clinic

   The objectives of this study is to evaluate the efficacy of Daratumumab as an HLA desensitization strategy prior to cardiac transplantation in highly-sensitized ...

10. Chella S. David, Ph.D. - Mayo Clinic Faculty Profiles

    SUMMARY. Immunogenetics. My research centers on immunogenetic aspects of immune response with emphasis on the major histocompatibility complex (MHC) HLA ...